Home > Qtrly Results > MANKIND PHARMA

MANKIND PHARMA
Quarterly Results Analysis [Dec2025]

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹3,567 Cr ₹3,697 Cr ₹3,570 Cr ₹3,079 Cr ₹3,199 Cr ₹3,061 Cr ₹2,868 Cr ₹2,422 Cr
Expenses ₹2,648 Cr ₹2,776 Cr ₹2,724 Cr ₹2,396 Cr ₹2,383 Cr ₹2,214 Cr ₹2,196 Cr ₹1,836 Cr
Operating Income ₹919 Cr ₹921 Cr ₹847 Cr ₹683 Cr ₹816 Cr ₹847 Cr ₹672 Cr ₹586 Cr
Other Income ₹73 Cr ₹92 Cr ₹80 Cr ₹251 Cr ₹77 Cr ₹109 Cr ₹99 Cr ₹92 Cr
Interest ₹157 Cr ₹170 Cr ₹171 Cr ₹191 Cr ₹221 Cr ₹7 Cr ₹11 Cr ₹9 Cr
Depreciation ₹223 Cr ₹222 Cr ₹219 Cr ₹231 Cr ₹187 Cr ₹100 Cr ₹103 Cr ₹100 Cr
Profit Before Tax ₹506 Cr ₹622 Cr ₹537 Cr ₹513 Cr ₹485 Cr ₹849 Cr ₹657 Cr ₹570 Cr
Profit After Tax ₹411 Cr ₹518 Cr ₹441 Cr ₹427 Cr ₹374 Cr ₹659 Cr ₹535 Cr ₹475 Cr
EPS ₹9.90 ₹12.39 ₹10.62 ₹10.20 ₹9.22 ₹16.31 ₹13.39 ₹11.76
Industry Peers & Returns1W1M1Y
MANKIND PHARMA 2.6% -2.1% -16.6%
SUN PHARMACEUTICAL INDUSTRIES 7.1% -1.5% -6.2%
DIVIS LABORATORIES 2.8% -2.8% 6%
CIPLA 0.2% -12.5% -7.9%
TORRENT PHARMACEUTICALS 3.1% 4.2% 18.8%
DR REDDYS LABORATORIES 2.2% -1.6% 0%
ZYDUS LIFESCIENCES 1.4% -1.5% -5.7%
LUPIN 2.6% 3.8% 2.9%
AUROBINDO PHARMA 6.6% 1% 1.6%

MANKIND PHARMA Quarterly Revenues

Revenues
Q-o-Q

-3.52 %

Y-o-Y

11.52 %

Quarters Revenues % Change
Dec2025 ₹3,567 Cr
-3.52
Sep2025 ₹3,697 Cr
3.55
Jun2025 ₹3,570 Cr
15.94
Mar2025 ₹3,079 Cr
-3.73
Dec2024 ₹3,199 Cr
4.49
Sep2024 ₹3,061 Cr
6.75
Jun2024 ₹2,868 Cr
18.40
Mar2024 ₹2,422 Cr -

MANKIND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-0.21 %

Y-o-Y

12.68 %

Quarters Operating Profit % Change
Dec2025 ₹919 Cr
-0.21
Sep2025 ₹921 Cr
8.81
Jun2025 ₹847 Cr
23.94
Mar2025 ₹683 Cr
-16.27
Dec2024 ₹816 Cr
-3.68
Sep2024 ₹847 Cr
26.15
Jun2024 ₹672 Cr
14.54
Mar2024 ₹586 Cr -
Operating Margins
Q-o-Q

3.41 %

Y-o-Y

1.02 %

Quarters Operating Margin% % Change
Dec2025 25.77%
3.41
Sep2025 24.92%
5.06
Jun2025 23.72%
6.89
Mar2025 22.19%
-13.01
Dec2024 25.51%
-7.81
Sep2024 27.67%
18.15
Jun2024 23.42%
-3.22
Mar2024 24.2% -

MANKIND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-20.70 %

Y-o-Y

9.68 %

Quarters Profit After Tax % Change
Dec2025 ₹411 Cr
-20.70
Sep2025 ₹518 Cr
17.31
Jun2025 ₹441 Cr
3.46
Mar2025 ₹427 Cr
13.95
Dec2024 ₹374 Cr
-43.15
Sep2024 ₹659 Cr
23.22
Jun2024 ₹535 Cr
12.66
Mar2024 ₹475 Cr -
PAT Margins
Q-o-Q

-17.84 %

Y-o-Y

-1.71 %

Quarters PAT Margin(%) % Change
Dec2025 11.51 %
-17.84
Sep2025 14.01 %
13.35
Jun2025 12.36 %
-10.82
Mar2025 13.86 %
18.36
Dec2024 11.71 %
-45.59
Sep2024 21.52 %
15.45
Jun2024 18.64 %
-4.85
Mar2024 19.59 % -

MANKIND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-20.10 %

Y-o-Y

7.38 %

Quarters EPS % Change
Dec2025 ₹9.9
-20.10
Sep2025 ₹12.39
16.67
Jun2025 ₹10.62
4.12
Mar2025 ₹10.2
10.63
Dec2024 ₹9.22
-43.47
Sep2024 ₹16.31
21.81
Jun2024 ₹13.39
13.86
Mar2024 ₹11.76 -

You may also like the below Video Courses